Correlation Between Tscan Therapeutics and 22822VAZ4

Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and 22822VAZ4 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and 22822VAZ4 into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tscan Therapeutics and CCI 29 15 MAR 27, you can compare the effects of market volatilities on Tscan Therapeutics and 22822VAZ4 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of 22822VAZ4. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and 22822VAZ4.

Diversification Opportunities for Tscan Therapeutics and 22822VAZ4

-0.42

Correlation Coefficient

Tscan Therapeutics  22822VAZ4

Very good diversification

The 3 months correlation between Tscan and 22822VAZ4 is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and CCI 29 15 MAR 27 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CCI 29 15 and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with 22822VAZ4. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CCI 29 15 has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and 22822VAZ4 go up and down completely randomly.

Pair Corralation between Tscan Therapeutics and 22822VAZ4

Given the investment horizon of 90 days Tscan Therapeutics is expected to under-perform the 22822VAZ4. In addition to that, Tscan Therapeutics is 3.77 times more volatile than CCI 29 15 MAR 27. It trades about -0.24 of its total potential returns per unit of risk. CCI 29 15 MAR 27 is currently generating about -0.03 per unit of volatility. If you would invest  9,591  in CCI 29 15 MAR 27 on December 25, 2024 and sell it today you would lose (235.00) from holding CCI 29 15 MAR 27 or give up 2.45% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	93.22%
Values	Daily Returns

Tscan Therapeutics  vs.  CCI 29 15 MAR 27

Tscan Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

CCI 29 15

Risk-Adjusted Performance

Very Weak

Over the last 90 days CCI 29 15 MAR 27 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 22822VAZ4 is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Tscan Therapeutics and 22822VAZ4

The main advantage of trading using opposite Tscan Therapeutics and 22822VAZ4 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, 22822VAZ4 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 22822VAZ4 will offset losses from the drop in 22822VAZ4's long position.

The idea behind Tscan Therapeutics and CCI 29 15 MAR 27 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.